Question 1

What is the catalog number for Human RRP36 activation kit by CRISPRa?

Accepted Answer

The catalog number for Human RRP36 activation kit by CRISPRa is GA113920.

Question 2

What sizes are available for Human RRP36 activation kit by CRISPRa?

Accepted Answer

Human RRP36 activation kit by CRISPRa is available in the following size(s): 1 Kit.

Question 3

Is Human RRP36 activation kit by CRISPRa in stock?

Accepted Answer

Human RRP36 activation kit by CRISPRa is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Where can I find the safety data sheet (SDS/MSDS) for Human RRP36 activation kit by CRISPRa?

Accepted Answer

The safety data sheet for Human RRP36 activation kit by CRISPRa is available here: https://cdn.origene.com/sds/ga113920.pdf.

Question 5

What is Human RRP36 activation kit by CRISPRa used for?

Accepted Answer

RRP36 CRISPRa kit - CRISPR gene activation of human ribosomal RNA processing 36

Question 6

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 7

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 8

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

Human RRP36 activation kit by CRISPRa

Product Specifications

UniProt

Gene Location

Symbol

Frequently Asked Questions

Explore Other Products

CD3E (NM_000733) Human Recombinant Protein

NFRKB Antibody

CD53 (161-2), CF405S conjugate, 0.1mg/mL

Frozen Tissue Sections, Prostate

Cytokeratin 8 (KRT8) (B22.1), CF640R conjugate, 0.1mg/mL

DL-Norepinephrine-d6 Hydrochloride, 85%